大电导钾离子通道(BK)结构与功能的研究进展

大电导钙离子激活钾通道(BK)是细胞膜上唯一接受细胞内Ca2+和膜电位双重调控的离子通道.最新发表的关于BK通道电镜结构及其胞质功能域的晶体结构的文章,第一次展示了BK通道各亚基的组装,并证实通道各功能域在通道门控机制中存在紧密的相互作用.近年来,针对BK通道的功能调节及其门控动力学模拟的研究取得较多进展,有助于更好地理解BK通道发挥生理功能的门控机制,并揭示BK通道相关疾病的病理生理学基础.     

低渗条件下小肠上皮细胞调节性细胞容积减小的离子通道机制

目的:观察人小肠上皮细胞调节性细胞容积减小(RVD)的过程,探讨参与RVD过程的离子通道机制.方法:将培养的人小肠上皮细胞暴露于低渗溶液, 利用电子细胞体积测量系统测定细胞平均容积变化过程和离子通道的参与过程;采用RT-PCR方法检测人小肠上皮细胞上离子通道的表达.结果:人小肠上皮细胞具有良好的RVD功能; 其RVD过程可被氯通道阻断剂NPPB 和钾通道阻断剂四乙铵所阻断; 进一步的研究发现, 中等电导钙激活性钾通道(IK)的特异性阻断剂Clotrimazole (CLT) (1μmol/L)可以明显抑制细胞的RVD过程,而大电导钙激活性钾通道(BK)和小电导钙激活性钾通道(SK)的特异阻断剂iberiotoxin (100 nmol/L)和apamin (100 nmol/L)对RVD过程无任何抑制作用.RT-PCR的结果也显示, 人小肠上皮细胞只有IK表达, 而无SK和BK的表达.结论:人小肠上皮细胞具有RVD功能,RVD过程的完成有赖于氯通道和钾通道的平行激活, 而其中参与容积调节的钾通道是中等电导钙激活型钾通道IK.     

BK通道在细胞膜上的单分子定位及空间分布

目的：研究大电导、钙离子和电压激活的钾离子通道（BK通道）在HEK293细胞膜上的单分子定位及其总体空间分布情况。方法：分别用mEos2、Dronpa等荧光蛋白标记BK通道的α亚基和辅助性β2亚基,将这些质粒在HEK293细胞内瞬时转染以表达通道蛋白,然后用激光共聚焦荧光显微成像、全内反射荧光显微成像、光敏定位荧光成像等技术观察BK通道的亚细胞定位及单分子分布,并用电生理实验技术检测荧光蛋白对BK通道有影响。结果：激光共聚焦荧光显微成像和全内反射荧光显微成像技术只能在亚细胞水平定位通道蛋白,BK通道在细胞膜上聚集并形成不规则的蛋白簇,它的仅亚基和β2亚基在细胞膜上完全共定位;光敏定位荧光成像技术成功定位BK通道蛋白簇里面的单分子,虽然α和β2亚基紧紧靠在一起,它们之间依然存在空间距离;BK通道的质膜表达和功能特性不受荧光蛋白的影响。结论：BK通道蛋白簇里面包含大量的α和β2亚基的蛋白单分子,它们紧密地聚集在一起,但是并没有完全共定位,在分子水平上揭示了BK通道α和p亚基功能耦合的结构基础,为以后研究大分子蛋白质间的相互作用机制提供了很好的分子模型,光敏定位荧光成像技术作为一种全新的单分子荧光成像手段,在基因表达、信号通路、蛋白质相互作用等许多重要生命活动的研究中发挥重要作用。     

大鼠背根神经节神经元上失活 BK 通道特性的研究

大电导的电压和 Ca²⁺ 激活的 K⁺ 通道 (BK 通道 ) 在哺乳动物的组织中广泛表达,起着多种多样的作用 . 目前只有少数组织中 BK 通道的性质被深入地研究,而且鲜见有失活的 BK 通道 (BK_i) 的报道,尤其是在神经元中 . 发现在大鼠小直径的背根神经节 (DRG) 神经元中,普遍存在失活的 BK 通道 . 失活的 BK 电流成分是 Ca²⁺敏感的,可以被大电导的 BK 通道特异阻断剂 ChTX 所阻断,而且木瓜蛋白酶可以从胞外改变通道失活的特性 .     

麻黄碱抑制支气管平滑肌细胞增殖的机制

BK通道(large-conductance Ca2 -activated K channel)是一种大电导、电压和钙离子依赖的钾通道,存在于哺乳动物几乎所有的组织中.β1亚基是首次从平滑肌细胞中分离到的一种BK通道辅助亚基.麻黄作为一种β肾上腺素受体激动剂,是一味治疗哮喘的常用中药.利用RT-PCR和膜片钳等技术,研究麻黄治疗哮喘的作用机制.结果表明:麻黄碱(ephedrine,Eph)作为麻黄的一种主要成分,显著抑制支气管平滑肌细胞(bronchial smooth muscle cells,BSMCs)的增殖和BK通道β1亚基的表达,但是对BK通道的电流没有显著影响.     

BK通道功能性复合体的研究进展

离子通道可以与其他蛋白质耦合形成稳定的大分子复合物,以确保信号转导的效率和准确性。大电导、钙离子激活的钾离子通道(BK通道)的核心是由形成孔区的α亚基组成的四聚体,它具有BK通道的基本生理功能。在不同的组织内,BKα可以与不同的辅助性亚基结合,使通道功能变得复杂多样。BK通道可以将细胞兴奋性与细胞内的钙离子信号联接在一起,在血流、泌尿、免疫、神经递质释放等许多生命过程中发挥着重要的调节作用。近年来,大量的研究工作表明,BK通道可以与钙离子通道、细胞骨架蛋白、蛋白激酶等生物大分子形成功能性复合物,这对通道功能调控和信号转导等生命活动具有重要的生理意义。本文综述了这些BK通道功能复合体的主要分类、功能特性以及生理学意义,并对其未来的研究前景进行展望。     

BK通道在细胞膜上的单分子定位及空间分布*

摘要目的：研究大电导、钙离子和电压激活的钾离子通道（BK通道）在HEK293 细胞膜上的单分子定位及其总体空间分布情况。 方法：分别用mEos2、Dronpa 等荧光蛋白标记BK通道的α亚基和辅助性β2 亚基,将这些质粒在HEK293 细胞内瞬时转染以表 达通道蛋白,然后用激光共聚焦荧光显微成像、全内反射荧光显微成像、光敏定位荧光成像等技术观察BK通道的亚细胞定位及 单分子分布,并用电生理实验技术检测荧光蛋白对BK通道有影响。结果：激光共聚焦荧光显微成像和全内反射荧光显微成像技 术只能在亚细胞水平定位通道蛋白,BK 通道在细胞膜上聚集并形成不规则的蛋白簇,它的α亚基和β2 亚基在细胞膜上完全共 定位;光敏定位荧光成像技术成功定位BK通道蛋白簇里面的单分子,虽然α和β2 亚基紧紧靠在一起,它们之间依然存在空间 距离;BK通道的质膜表达和功能特性不受荧光蛋白的影响。结论：BK通道蛋白簇里面包含大量的α和β2 亚基的蛋白单分子, 它们紧密地聚集在一起,但是并没有完全共定位,在分子水平上揭示了BK通道α和β亚基功能耦合的结构基础,为以后研究大 分子蛋白质间的相互作用机制提供了很好的分子模型,光敏定位荧光成像技术作为一种全新的单分子荧光成像手段,在基因表 达、信号通路、蛋白质相互作用等许多重要生命活动的研究中发挥重要作用。     

蝎β型昆虫毒素的结构及其与钠通道作用机制

蝎毒素是蝎为防卫的需要而产生的一系列活性短肽.其中蝎昆虫特异性毒素可特异性结合并调控昆虫可兴奋细胞膜上的钠离子通道,是研究离子通道结构与功能的首选探针,并在转基因抗虫植物及生物杀虫剂研究方面具有潜在的应用价值.本文对蝎β型昆虫毒素的结构与功能及其对钠离子通道的作用方式和β毒素的电压传感器捕获(voltage sensor-trapping)模型做一综述,为进一步揭示蝎β毒素的结构与功能的关系和在农作物抗虫领域的应用提供依据.     

BK通道的生物物理特性与门控及其最新研究进展

BK_(Ca)通道是细胞膜上受Ca~(2+)和膜电位双重调控的离子通道,其与细胞信号系统偶联并发挥着重要作用,该通道高度表达于高等动物的多种组织.最近的研究证实,在心肌细胞膜上存在力敏感BK通道并参与了心脏收缩与舒张的调控.本文将介绍BK通道与L-型钙通道功能上的耦合,心肌细胞质膜力敏感BK通道门控和功能的研究,以及对基底刚度的响应.这有助于更好地理解力敏感离子通道相关心脏疾病的病理和生理学基础.     

BK通道功能性复合体的研究进展

离子通道可以与其他蛋白质耦合形成稳定的大分子复合物,以确保信号转导的效率和准确性。大电导、钙离子激活的钾离子通道（BK通道）的核心是由形成孔区的d亚基组成的四聚体,它具有BK通道的基本生理功能。在不同的组织内,BKα可以与不同的辅助性亚基结合,使通道功能变得复杂多样。BK通道可以将细胞兴奋性与细胞内的钙离子信号联接在一起,在血流、泌尿、免疫、神经递质释放等许多生命过程中发挥着重要的调节作用。近年来,大量的研究工作表明。BK通道可以与钙离子通道、细胞骨架蛋白、蛋白激酶等生物大分子形成功能性复合物,这对通道功能调控和信号转导等生命活动具有重要的生理意义。本文综述了这些BK通道功能复合体的主要分类、功能特性以及生理学意义,并对其未来的研究前景进行展望。     

Inhibition of martentoxin on neuronal BK channel subtype (alpha+beta4): implications for a novel interaction model

Martentoxin as a 37-residue peptide was capable of blocking large-conductance Ca²⁺-activated K⁺ (BK) channels in adrenal medulla chromaffin cells. This study investigated the pharmacological discrimination of martentoxin on BK channel subtypes. The results showed that the iberiotoxin-insensitive neuronal BK channels (α+β4) could be potently blocked by martentoxin (IC₅₀ = ∼80 nM). In contrast, the iberiotoxin-sensitive BK channel consisting of only α-subunit was less sensitive to martentoxin. Distinctively, martentoxin inhibited neuronal BK channels (α+β4) with a novel interaction mode. Two possible interaction sites of neuronal BK channels (α+β4) might be responsible for the binding with martentoxin: one for trapping and the other located at the pore region for blocking. In addition, the inhibition of martentoxin on neuronal BK channels (α+β4) depended on cytoplasmic Ca²⁺ concentration. On the other hand, in vivo experiments from EEG recordings suggested that neuronal BK channels (α+β4) were the primary target of martentoxin. Therefore, this research not only sheds light on a unique ligand for neuronal BK channels (α+β4), but also highlights a novel model approach for the interaction between K⁺ channels and specific-ligands.     

Enhancement effects of martentoxin on glioma BK channel and BK channel (α+β1) subtypes

Background

BK channels are usually activated by membrane depolarization and cytoplasmic Ca²⁺. Especially,the activity of BK channel (α+β4) can be modulated by martentoxin, a 37 residues peptide, with Ca²⁺-dependent manner. gBK channel (glioma BK channel) and BK channel (α+β1) possessed higher Ca²⁺ sensitivity than other known BK channel subtypes.

Methodology and Principal Findings

The present study investigated the modulatory characteristics of martentoxin on these two BK channel subtypes by electrophysiological recordings, cell proliferation and Ca²⁺ imaging. In the presence of cytoplasmic Ca²⁺, martentoxin could enhance the activities of both gBK and BK channel (α+β1) subtypes in dose-dependent manner with EC₅₀ of 46.7 nM and 495 nM respectively, while not shift the steady-state activation of these channels. The enhancement ratio of martentoxin on gBK and BK channel (α+β1) was unrelated to the quantitive change of cytoplasmic Ca²⁺ concentrations though the interaction between martentoxin and BK channel (α+β1) was accelerated under higher cytoplasmic Ca²⁺. The selective BK pore blocker iberiotoxin could fully abolish the enhancement of these two BK subtypes induced by martentoxin, suggesting that the auxiliary β subunit might contribute to the docking for martentoxin. However, in the absence of cytoplasmic Ca²⁺, the activity of gBK channel would be surprisingly inhibited by martentoxin while BK channel (α+β1) couldn''t be affected by the toxin.

Conclusions and Significance

Thus, the results shown here provide the novel evidence that martentoxin could increase the two Ca²⁺-hypersensitive BK channel subtypes activities in a new manner and indicate that β subunit of these BK channels plays a vital role in this enhancement by martentoxin.     

Scorpion venom inhibits selectively Ca2+-activated K+ channels in situ

Using patch-clamp techniques, a study was made of the component of Leiurus quinquestriatus scorpion venom which caused a blockade of one class of membrane potassium channels, the calcium activated potassium (BK) channels. This blockade was obtained on channels in their native lipidic environment and was specific for this class of channels as other types of potassium channels were not affected by this venom.     

Martentoxin,a novel K+-channel-blocking peptide: purification,cDNA and genomic cloning,and electrophysiological and pharmacological characterization

Martentoxin, a novel K+-channel-specific peptide has been purified and characterized from the venom of the East-Asian scorpion (Buthus martensi Karsch). The whole cDNA precursor sequence suggested that martentoxin was composed of 37 residues with a unique sequence compared with other scorpion neurotoxins. The genomic DNA of martentoxin showed an additional intron situated unexpectedly in the 5' UTR region, besides one located close to the C-terminal of the signal peptide. The patch-clamp recording found that martentoxin at the applied dose of 100 nm could strongly block large-conductance Ca2+-activated K+ (BKCa) currents in adrenal medulla chromaffin cells, and BKCa currents blocked by martentoxin could be fully recovered within 30 seconds after washing, which is at least 10 times faster than recovery after charybdotoxin. Meanwhile, a biosensor binding assay showed a fast association rate and a slow dissociation rate of martentoxin binding on rat brain synaptosomes. The binding of martentoxin on rat brain synaptosomes could be inhibited regularly by charybdotoxin, and gradually by toosendanin in a concentration-dependent manner, but not by either apamin or P03 from Buthus martensi. The results thus indicate that martentoxin is a new member in the family of K+-channel-blocking ligands.     

Hemeoxygenase-2 as an O2 sensor in K+ channel-dependent chemotransduction

The physiological response of the carotid body is critically dependent upon oxygen-sensing by potassium channels expressed in glomus cells. One such channel is the large conductance, voltage- and calcium-dependent potassium channel, BK(Ca). Although it is well known that a decrease in oxygen evokes glomus cell depolarization, voltage-gated calcium entry, and transmitter release, the molecular identity of the upstream oxygen sensor has been the subject of some controversy for decades. Recently, we have demonstrated that hemeoxygenase-2 associates tightly with recombinant BK(Ca) and that activity of this enzyme confers oxygen sensitivity to the BK(Ca) channel complex. Similar observations were also made in native channels recorded from carotid body glomus cells, suggesting that hemoxygenase-2 functions as an oxygen sensor of native and recombinant BK(Ca) channels.     

Kv1.3 potassium channel-blocking toxin Ctri9577, novel gating modifier of Kv4.3 potassium channel from the scorpion toxin family

Scorpion toxin Ctri9577, as a potent Kv1.3 channel blocker, is a new member of the α-KTx15 subfamily which are a group of blockers for Kv4.x potassium channels. However, the pharmacological function of Ctri9577 for Kv4.x channels remains unknown. Scorpion toxin Ctri9577 was found to effectively inhibit Kv4.3 channel currents with IC₅₀ value of 1.34 ± 0.03 μM. Different from the mechanism of scorpion toxins as the blocker recognizing channel extracellular pore entryways, Ctri9577 was a novel gating modifier affecting voltage dependence of activation, steady-state inactivation, and the recovery process from the inactivation of Kv4.3 channel. However, Ctri9755, as a potent Kv1.3 channel blocker, was found not to affect voltage dependence of activation of Kv1.3 channel. Interestingly, pharmacological experiments indicated that 1 μM Ctri9755 showed less inhibition on Kv4.1 and Kv4.2 channel currents. Similar to the classical gating modifier of spider toxins, Ctri9577 was shown to interact with the linker between the transmembrane S3 and S4 helical domains through the mutagenesis experiments. To the best of our knowledge, Ctri9577 was the first gating modifier of potassium channels among scorpion toxin family, and the first scorpion toxin as both gating modifier and blocker for different potassium channels. These findings further highlighted the structural and functional diversity of scorpion toxins specific for the potassium channels.     

Hg1, novel peptide inhibitor specific for Kv1.3 channels from first scorpion Kunitz-type potassium channel toxin family

The potassium channel Kv1.3 is an attractive pharmacological target for autoimmune diseases. Specific peptide inhibitors are key prospects for diagnosing and treating these diseases. Here, we identified the first scorpion Kunitz-type potassium channel toxin family with three groups and seven members. In addition to their function as trypsin inhibitors with dissociation constants of 140 nM for recombinant LmKTT-1a, 160 nM for LmKTT-1b, 124 nM for LmKTT-1c, 136 nM for BmKTT-1, 420 nM for BmKTT-2, 760 nM for BmKTT-3, and 107 nM for Hg1, all seven recombinant scorpion Kunitz-type toxins could block the Kv1.3 channel. Electrophysiological experiments showed that six of seven scorpion toxins inhibited ~50-80% of Kv1.3 channel currents at a concentration of 1 μM. The exception was rBmKTT-3, which had weak activity. The IC(50) values of rBmKTT-1, rBmKTT-2, and rHg1 for Kv1.3 channels were ~129.7, 371.3, and 6.2 nM, respectively. Further pharmacological experiments indicated that rHg1 was a highly selective Kv1.3 channel inhibitor with weak affinity for other potassium channels. Different from classical Kunitz-type potassium channel toxins with N-terminal regions as the channel-interacting interfaces, the channel-interacting interface of Hg1 was in the C-terminal region. In conclusion, these findings describe the first scorpion Kunitz-type potassium channel toxin family, of which a novel inhibitor, Hg1, is specific for Kv1.3 channels. Their structural and functional diversity strongly suggest that Kunitz-type toxins are a new source to screen and design potential peptides for diagnosing and treating Kv1.3-mediated autoimmune diseases.     

Alternative splicing switches potassium channel sensitivity to protein phosphorylation

Alternative exon splicing and reversible protein phosphorylation of large conductance calcium-activated potassium (BK) channels represent fundamental control mechanisms for the regulation of cellular excitability. BK channels are encoded by a single gene that undergoes extensive, hormonally regulated exon splicing. In native tissues BK channels display considerable diversity and plasticity in their regulation by cAMP-dependent protein kinase (PKA). Differential regulation of alternatively spliced BK channels by PKA may provide a molecular basis for the diversity and plasticity of BK channel sensitivities to PKA. Here we demonstrate that PKA activates BK channels lacking splice inserts (ZERO) but inhibits channels expressing a 59-amino acid exon at splice site 2 (STREX-1). Channel activation is dependent upon a conserved C-terminal PKA consensus motif (S869), whereas inhibition is mediated via a STREX-1 exon-specific PKA consensus site. Thus, alternative splicing acts as a molecular switch to determine the sensitivity of potassium channels to protein phosphorylation.     

Up-Regulatory Effects of Curcumin on Large Conductance Ca2+-Activated K+ Channels

Large conductance Ca²⁺-activated potassium channels (BK) are targets for research that explores therapeutic means to various diseases, owing to the roles of the channels in mediating multiple physiological processes in various cells and tissues. We investigated the pharmacological effects of curcumin, a compound isolated from the herb Curcuma longa, on BK channels. As recorded by whole-cell patch-clamp, curcumin increased BK (α) and BK (α+β1) currents in transfected HEK293 cells as well as the current density of BK in A7r5 smooth muscle cells in a dose-dependent manner. By incubating with curcumin for 24 hours, the current density of exogenous BK (α) in HEK293 cells and the endogenous BK in A7r5 cells were both enhanced notably, though the steady-state activation of the channels did not shift significantly, except for BK (α+β1). Curcumin up-regulated the BK protein expression without changing its mRNA level in A7r5 cells. The surface expression and the half-life of BK channels were also increased by curcumin in HEK293 cells. These effects of curcumin were abolished by MG-132, a proteasome inhibitor. Curcumin also increased ERK 1/2 phosphorylation, while inhibiting ERK by U0126 attenuated the curcumin-induced up-regulation of BK protein expression. We also observed that the curcumin-induced relaxation in the isolated rat aortic rings was significantly attenuated by paxilline, a BK channel specific blocker. These results show that curcumin enhances the activity of the BK channels by interacting with BK directly as well as enhancing BK protein expression through inhibiting proteasomal degradation and activating ERK signaling pathway. The findings suggest that curcumin is a potential BK channel activator and provide novel insight into its complicated pharmacological effects and the underlying mechanisms.